Eli Lilly Share Price (LLY.US)

Eli Lilly & Co is listed on the CBOE trading with ticker code LLY.US. It has a market capitalisation of $935.43b, with approximately 950.03m shares in issue. Over the last year, Eli Lilly share price has been traded in a range of 509.52, hitting a high of 1,133.52, and a low of 624.00.

Eli Lilly and Company is a global pharmaceutical firm headquartered in Indianapolis, Indiana. Founded in 1876 by Colonel Eli Lilly, it is renowned for its innovative research and development in the medical field. The company specialises in creating medicines for oncology, endocrinology, neuroscience, and immunology. Notable products include Prozac, Humalog, and Trulicity. Committed to advancing healthcare, Eli Lilly focuses on discovering and delivering high-quality medications that improve patient outcomes. With a strong emphasis on scientific excellence and corporate responsibility, Eli Lilly continues to play a pivotal role in the global pharmaceutical industry.